Qvr LLC Bristol Myers Squibb CO Put Options Transaction History

Qvr LLC

9 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q4 2022 Feb 10, 2023	SELL	$68.48 - $81.09 $1.8 Million - $2.13 Million	-26,300 Reduced 84.84%	4,700 $338,000
Q3 2022 Oct 25, 2022	SELL	$0.13 - $76.84 $2,626 - $1.55 Million	-20,200 Reduced 39.45%	31,000 $2.2 Million
Q2 2022 Aug 01, 2022	SELL	$72.62 - $79.98 $1.57 Million - $1.73 Million	-21,600 Reduced 29.67%	51,200 $3.94 Million
Q1 2022 Apr 27, 2022	BUY	$61.48 - $73.72 $4.48 Million - $5.37 Million	72,800 New	72,800 $5.32 Million
Q4 2021 Jan 31, 2022	SELL	$53.63 - $62.52 $2.18 Million - $2.54 Million	-40,700 Closed	0 $0
Q3 2021 Nov 02, 2021	BUY	$59.17 - $69.31 $473,360 - $554,480	8,000 Added 24.46%	40,700 $2.41 Million
Q2 2021 Aug 16, 2021	BUY	$61.91 - $67.42 $1.72 Million - $1.87 Million	27,800 Added 567.35%	32,700 $2.19 Million
Q1 2021 May 03, 2021	SELL	$59.34 - $66.74 $77,142 - $86,762	-1,300 Reduced 20.97%	4,900 $309,000
Q4 2020 Jan 29, 2021	BUY	$57.74 - $65.43 $357,988 - $405,666	6,200 New	6,200 $385,000

2,533

1.47B

31.6M

35M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $125B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Qvr LLC, based on Form 13F filings with the SEC.

Stay updated on Qvr LLC with notifications on news.